1. Home
  2. CABA vs INVZ Comparison

CABA vs INVZ Comparison

Compare CABA & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • INVZ
  • Stock Information
  • Founded
  • CABA 2017
  • INVZ 2016
  • Country
  • CABA United States
  • INVZ Israel
  • Employees
  • CABA N/A
  • INVZ N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • INVZ Auto Parts:O.E.M.
  • Sector
  • CABA Health Care
  • INVZ Consumer Discretionary
  • Exchange
  • CABA Nasdaq
  • INVZ Nasdaq
  • Market Cap
  • CABA 157.4M
  • INVZ 186.3M
  • IPO Year
  • CABA 2019
  • INVZ N/A
  • Fundamental
  • Price
  • CABA $1.63
  • INVZ $1.44
  • Analyst Decision
  • CABA Strong Buy
  • INVZ Strong Buy
  • Analyst Count
  • CABA 7
  • INVZ 5
  • Target Price
  • CABA $14.43
  • INVZ $3.38
  • AVG Volume (30 Days)
  • CABA 3.0M
  • INVZ 9.4M
  • Earning Date
  • CABA 08-07-2025
  • INVZ 08-06-2025
  • Dividend Yield
  • CABA N/A
  • INVZ N/A
  • EPS Growth
  • CABA N/A
  • INVZ N/A
  • EPS
  • CABA N/A
  • INVZ N/A
  • Revenue
  • CABA N/A
  • INVZ $34,601,000.00
  • Revenue This Year
  • CABA N/A
  • INVZ $137.25
  • Revenue Next Year
  • CABA N/A
  • INVZ $128.53
  • P/E Ratio
  • CABA N/A
  • INVZ N/A
  • Revenue Growth
  • CABA N/A
  • INVZ 28.52
  • 52 Week Low
  • CABA $0.99
  • INVZ $0.45
  • 52 Week High
  • CABA $8.77
  • INVZ $3.14
  • Technical
  • Relative Strength Index (RSI)
  • CABA 44.25
  • INVZ 62.62
  • Support Level
  • CABA $1.65
  • INVZ $1.20
  • Resistance Level
  • CABA $1.68
  • INVZ $1.58
  • Average True Range (ATR)
  • CABA 0.14
  • INVZ 0.17
  • MACD
  • CABA -0.05
  • INVZ 0.02
  • Stochastic Oscillator
  • CABA 23.53
  • INVZ 72.00

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: